Home › Funds › Rock Springs Capital Management LP › ASND

Rock Springs Capital Management LP position in ASND

ASCENDIS PHARMA A/S · Health Care

Rock Springs Capital Management LP reported holding 144,000 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$32.8M, representing 1.78% of its reported portfolio and ranking #11 among its reported holdings. Rock Springs Capital Management LP has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)144.00K sh
Reported value held$32.81M
Portfolio Weight1.78%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's ASND position evolved

Rock Springs Capital Management LP first disclosed a stake in ASND in Q3 2023 at 425,500 shares (US$39.8M). The position peaked in Q3 2024 at 325,000 shares, worth US$48.5M. Across 13 filings, Rock Springs Capital Management LP increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 144,000 shares valued at US$32.8M — a reduction of -24,750 shares quarter over quarter.. Notable position changes include a 32% trim in Q4 2023 (shares rose 20% over the following quarter), a 29% trim in Q1 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 425.50K $39.84M New
Q4 2023 290.00K $36.53M Reduce
Q1 2024 290.00K $43.84M Hold
Q2 2024 290.00K $39.55M Hold
Q3 2024 325.00K $48.53M Add
Q4 2024 305.00K $41.99M Reduce
Q1 2025 216.00K $33.67M Reduce
Q2 2025 217.00K $37.45M Hold
Q3 2025 214.50K $42.64M Reduce
Q4 2025 203.50K $43.39M Reduce
Q1 2026 194.00K $44.37M Reduce
Q2 2026 168.75K $45.01M Reduce
Q3 2026 144.00K $32.81M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 36 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), WESTFIELD CAPITAL MANAGEMENT CO LP (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Rock Springs Capital Management LP held ASND?

Rock Springs Capital Management LP has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in ASND?

As of Q3 2026, Rock Springs Capital Management LP holds 144.00K shares of ASND (ASCENDIS PHARMA A/S), valued at $32.81M, representing 1.78% of its reported portfolio and ranking #11.

Has Rock Springs Capital Management LP been buying or selling ASND?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in ASND. The position peaked in Q3 2024 at 325.00K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., WESTFIELD CAPITAL MANAGEMENT CO LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.